Loading...
XWAR
NEU
Market cap874mUSD
Jun 19, Last price  
719.00PLN
1D
-0.14%
1Q
2.42%
Jan 2017
84.36%
IPO
1,564.35%
Name

Neuca SA

Chart & Performance

D1W1MN
XWAR:NEU chart
P/E
21.00
P/S
0.26
EPS
34.23
Div Yield, %
2.22%
Shrs. gr., 5y
-0.19%
Rev. gr., 5y
8.78%
Revenues
13.64b
+8.18%
1,700,854,0003,288,786,0003,969,629,0005,687,344,0006,131,679,0006,388,658,0005,687,431,0005,795,092,0006,568,700,0006,945,703,0007,077,194,0007,485,234,0007,753,263,0008,278,727,0009,254,014,0009,864,258,00011,232,540,00011,812,636,00012,611,751,00013,643,615,000
Net income
156m
+0.87%
11,275,00016,350,00014,104,00036,336,00037,563,00053,192,00066,016,00085,347,00093,070,000101,284,000111,727,00094,497,00098,274,000117,655,000141,791,000150,655,000137,238,000146,269,000154,244,000155,579,000
CFO
497m
+685.30%
-11,013,00084,072,00035,614,00048,994,00014,111,000166,079,000124,920,00027,696,000202,556,000180,402,000175,049,000121,764,000121,935,000202,247,000324,671,000300,198,000335,937,000288,271,00063,229,000496,535,000
Dividend
Jul 15, 202516 PLN/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

NEUCA S.A., headquartered in Torun, Poland, specializes in supplying pharmaceutical products to pharmacies and healthcare facilities throughout the country. The firm structures its business around distinct segments: wholesale pharmaceutical distribution, the development and marketing of proprietary drug brands, and a comprehensive healthcare services division. This healthcare arm specifically encompasses outpatient care, clinical trials, and telemedicine. Beyond these core areas, NEUCA S.A. provides an extensive array of additional services, including marketing and advertising support, agency functions, financial solutions, logistics through road cargo transport, accounting and bookkeeping, software development, information technology support, and specialized services for hospitals. The company also offers various insurance products—covering health, property, and other personal lines—and operates its own network of medical supply stores. Established in 1990 as Torfarm SA, the company rebranded to NEUCA S.A. in April 2010.
IPO date
Sep 30, 2004
Employees
3,981
Domiciled in
PL
Incorporated in
PL

Valuation

Title
PLN in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT